N/A Completed N=1,674 Screening

Validation of a Screening Tool in Geriatric Oncology

Breast Cancer · Colorectal Cancer · Head and Neck Cancer · Lung Cancer

Source: ClinicalTrials.gov NCT00963911 ↗

Enrolled (actual)

1,674

Serious AEs

0.0%

Results posted

Jan 2021

Primary outcomePrimary: Sensitivity of the G8 Questionnaire — 76.5 % of Participants with a positive G8

Summary

RATIONALE: A screening questionnaire may help doctors plan better treatment for older patients with cancer. PURPOSE: This clinical trial is studying a questionnaire in screening older patients with cancer.

Outcome Measures

Outcome	Result	p-value
PRIMARY Sensitivity of the G8 Questionnaire	76.5	—
SECONDARY Specificity of the G8 Questionnaire	64.4	—
SECONDARY Sensitivity of the VES-13 Questionnaire	68.7	—
SECONDARY Specificity of the VES-13 Questionnaire	74.3	—
SECONDARY Reproducibility of the G8 Questionnaire	0.65	—
SECONDARY Reproducibility of the VES-13 Questionnaire	0.64	—

Eligibility Criteria

DISEASE CHARACTERISTICS:

Histologically confirmed cancer including the following types:
Colon
Rectal
Lung
Squamous cell carcinoma of the head and neck
Breast
Prostate
Non-Hodgkin lymphoma
Planning to undergo first-time treatment comprising medicine, surgery, or radiotherapy

PATIENT CHARACTERISTICS:

No persons deprived of liberty or under guardianship
No psychological, familial, social, or geographical reasons that would make monitoring clinically impossible

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00963911). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.